Publication Cover
Acta Clinica Belgica
International Journal of Clinical and Laboratory Medicine
Volume 62, 2007 - Issue 4
169
Views
0
CrossRef citations to date
0
Altmetric
Continuing Medical Eduation

THE KIDNEY IN THE CRITICALLY ILL

Pages 195-207 | Published online: 09 Jan 2014

REFERENCES

  • Liano F, Junco E, Pascual J, Madero R, Verde E.The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. The Madrid Acute Renal Failure Study Group. Kidney Int Suppl. 1998; 66:S16–24.
  • Vincent JL, de Mendonca A, Cantraine F, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: Results of a multicentric, prospective study. Crit Care Med. 1998; 26: 1793–800.
  • Mehta RL, Pascual MT, Soroko S, et al; For the Program to Im-prove Care in Acute Renal Disease (PICARD). Spectrum of acute renal failure in the intensive care unit: The PICARD ex-perience. Kidney Int. 2004; 66:1613–21.
  • Brivet FG, Kleinknecht DJ, Loirat P, Landais PJ. Acute renal fai-lure in intensive care units--causes, outcome, and prognostic factors of hospital mortality; a prospective, multicenter study. French Study Group on Acute Renal Failure. Crit Care Med. 1996; 24: 192–8.
  • Uchino S, Kellum JA, Bellomo R, et al: Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investiga-tors. Acute renal failure in critically iR patients: a multinatio-nal, multicenter study. JAMA. 2005; 294: 813–8.
  • Ympa YP, Sakr Y, Reinhart K, Vincent JL. Has mortality from acute renal failure decreased? A systematic review of the li-terature. Am J Med. 2005; 118:827–32.
  • Hoste E, Kellum J. ARF in the criticallyimpact on morbidityand mortality. Contrib Nephrol. 2004; 144:1–11.
  • Levy EM, Viscoli CM, Horwitz RI.The effect of acute renal failure on mortality. A cohort analysis. JAMA. 1996; 275: 1489–94.
  • Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med. 1998; 104: 343–8.
  • Lassnigg A, Schmidlin D, Mouhieddine M, et al. Minimal chan-ges of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol. 2004; 15: 1597–605.
  • Metnitz PGH, Krenn CG, Steltzer H, et al. Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med. 2002; 30: 2051–8.
  • Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute Kidney Injury, Mortality, Length of Stay, and Costs in Hospitalized Patients. J Am Soc Nephrol. 2005; 16: 3365–70.
  • Riegel W. Continuous renal replacement therapy in acute renal failure. Kidney Blood Press Res. 2003; 26: 123–7.
  • Rondon-Berrios H, Palevsky PM. Treatment of acute kidney injury: an update on the management of renal replacement therapy. Curr Opin Nephrol Hypertens. 2007; 16: 64–70.
  • Silvester W, Bellomo R, Cole L. Epidemiology, management, and outcome of severe acute renal failure of critical illness in Australia. Crit Care Med. 2001; 29: 1910–5.
  • Korkeila M, Ruokonen E, Takala J. Costs of care, long-term prognosis and quality of life in patients requiring renal re-placement therapy during intensive care. Intensive Care Med. 2000; 26: 1824–31.
  • Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficien-cy. Am J Kidney Dis. 2002; 39: 930–6.
  • Bagshaw SM, Lau pland KB, Doig CJ, et al. Prognosis for long-term survival and renal recovery in critically iR patients with severe acute renal failure: a population-based study. Crit Care. 2005; 9: R700–9.
  • Andersson LG, Ekroth R, Bratteby LE, Hallhagen S, Wesslen O. Acute rearil failure after coronary surgery - a study of inci-dence and risk factors in 2009 consecutive patients. Thorac Cardiovasc Surg. 1993; 41: 237–41.
  • Zanardo G, Michielon P, Paccagnella A, et al. Acute renal fai-lure in the patient undergoing cardiac operation. Prevalence, mortality rate, and main risk factors.J Thorac Cardiovasc Surg. 1994; 107: 1489–95.
  • Schwilk B, Wiedeck H, Stein B, Reinelt H, Treiber H, Bothner U. Epidemiology of acute renal failure and outcome of haemo-diafiltration in intensive care. Intensive Care Med. 1997; 23: 1204–11.
  • Chertow GM, Lazarus JM, Christiansen CL, et al. Preoperative renal risk stratification. Circulation. 1997; 95: 878–84.
  • Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT. Renal dysfunction after myocar-dial revascularization: Risk factors, adverse outcomes, and hospital resource utilization. Ann Intern Med. 1998; 128: 194–203.
  • Ostermann ME, Taube D, Morgan CJ, Evans TW. Acute renal failure following cardiopulmonary bypass: a changing picture. Intensive Care Med. 2000; 26: 565–71.
  • de Mendonca A, Vincent JL, Suter PM, et al. Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score. Intensive Care Med. 2000; 26: 915–21.
  • Guerin C, Girard R, Selli JM, Perdrix JP, Ayzac L. Initial versus delayed acute renal failure in the intensive care unit. A multi-center prospective epidemiological study. Rhone-Alpes Area Study Group on Acute Renal Failure. Am J Respir Crit Care Med. 2000; 161:872–9.
  • Clermont G, Acker CG, Angus DC, Sirio CA, Pinsky MR, Johnson JP. Renal failure in the ICU: comparison of the impact of acute renal failure and end-stage renal disease on ICU outcomes. Kidney Int. 2002; 62: 986–96.
  • Bove T, Calabro MG, Landoni G, et al.The incidence and risk of acute renal failure after cardiac surgery. J Cardiothorac Vasc Anesth. 2004; 18:442–5.
  • Schroeder TH, Hansen M, Dinkelaker K, et al. Influence of un-derlying disease on the outcome of critically iR patients with acute renal failure. Eur J Anaesthesiol. 2004; 21:848–53.
  • Bagshaw SM, Mortis G, Doig CJ, Godinez-Luna T, Fick GH, Lau-pland KB. One-year mortality in critically iR patients by seve-rity of kidney dysfunction: a population-based assessment. Am J Kidney Dis. 2006; 48:402–9.
  • Mataloun SE, Machado FR, Senna AP, Guimaraes HP, Amaral JL. Incidence, risk factors and prognostic factors of acute renal failure in patients admitted to an intensive care unit. Braz J Med Biol Res. 2006; 39: 1339–47.
  • Herrera-Gutierrez ME, Seller-Perez G, Maynar-Moliner J, San-chez-Izquierdo-Riera JA. Epidemiology of acute kidney failure in Spanish ICU. Multicenter prospective study FRAMI. Med Intensiva. 2006; 30: 260–7.
  • Hoste EAJ, Clermont G, Kersten A, et al. RIFLE criteria for acu-te kidney injury are associated with hospital mortality in cri-tically ill patients: a cohort analysis. Crit Care. 2006; 10: R73–82.
  • Leblanc M, Kellum JA, Gibney RTN, Lieberthal W, Tumlin J, Mehta R. Risk factors for acute renal failure: inherent and mo-difiable risks. Curr Opin Crit Care. 2005; 11:533–6.
  • Fortescue EB, Bates DW, Chertow GM. Predicting acute renal failure after coronary bypass surgery: cross-validation of two risk-stratification algorithms. Kidney Int. 2000; 57: 2594–602.
  • Eriksen BO, Hoff KR, Solberg S. Prediction of acute renal fai-lure after cardiac surgery: retrospective cross-validation of a clinical algorithm. Nephrol Dial Transplant. 2003; 18: 77–81.
  • Thakar CV, Arrigain S, Worley S, Yared JP, Paganini EP. A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol. 2005; 16: 162–8.
  • Mehran R, Aymong ED, Nikolsky E, et al A simple risk score for prediction of contrast-induced nephropathy after percutane-ous coronary intervention: development and initial valida-tion. J Am Coll Cardiol. 2004; 44: 1393–9.
  • Lameire N, Van Biesen W, Vanholder R. The changing epidemi-ology of acute renal failure. Nat Clin Pract Nephrol. 2006; 2:364–77.
  • Lameire N, Hoste E. Reflections on the definition, classifica-tion, and diagnostic evaluation of acute renal failure. Curr Opin Crit Care. 2004; 10: 468–75.
  • Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function--measured and estimated glomerular filtration rate. N EngIJ Med. 2006; 354: 2473–83.
  • Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P; The ADQI workgroup: Acute renal failure - definition, outcome measures, animal models, fluid therapy and information tech-nology needs: the Second International Consensus Confe-rence of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004; 8: R204–12.
  • Herget-Rosenthal S, Marggraf G, Husing J, et al. Early detec-tion of acute renal failure by serum cystatin C. Kidney Int. 2004; 66:1115–22.
  • Wagener G, Jan M, Kim M, et al. Association between Increa-ses in Urinary Neutrophil Gelatinase-associated Lipocalin and Acute Renal Dysfunction after Adult Cardiac Surgery. Anes-thesiology. 2006; 105:485–91.
  • Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-as-sociated lipocalin (NGAL) as a biomarker for acute renal in-jury after cardiac surgery. Lancet. 2005; 365: 1231–8.
  • Parikh CR, Abraham E, Ancukiewicz M, Edelstein CL. Urine IL-18 Is an Early Diagnostic Marker for Acute Kidney Injury and Predicts Mortality in the Intensive Care Unit.JAm SocNeph-rol. 2005; 16: 3046–52.
  • Obialo CI, Okonofua EC, Tayade AS, Riley Li. Epidemiology of de novo acute renal failure in hospitalized African Americans: comparing community-acquired vs hospital-acquired disease. Arch Intern Med. 2000; 160:1309–13.
  • Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N EngIJ Med. 1996; 334:1448–60.
  • Schrier RW, Wang W, Poole B, Mitra A. Acute renal failure: de-finitions, diagnosis, pathogenesis, and therapy. J Clin Invest. 2004; 114:5–14.
  • Brezis M, Rosen S. Hypoxia of the renal medulla-its implica-tions for disease. N Engl J Med. 1995; 332:647–55.
  • Badr KF, Ichikawa I. Prerenal failure: a deleterious shift from renal compensation to decompensation. N Engl J Med. 1988; 319:623–9.
  • Pallone TL, Zhang Z, Rhinehart K. Physiology of the renal mi-crocirculation. Am J Physiol Renal Physiol. 2003; 284: F253–66.
  • Brezis M, Rosen S, Silva P, Epstein FH. Renal ischemia: a new perspective. Kidney Int. 1984; 26:375–83.
  • Thu rau K, Boylan JW. Acute renal success. The unexpected lo-gic of oliguria in acute renal failure. Am J Med. 1976; 61: 308–14.
  • Devarajan P. Update on Mechanisms of Ischemic Acute Kidney I nj u ry. J Am Soc Nephrol. 2006; 17:1503–20.
  • Lameire N, Van Biesen W, Vanholder R. Acute renal failure. Lancet. 2005; 365:417–30.
  • Friedewald JJ, Rabb H. Inflammatory cells in ischemic acute renal failure. Kidney Int. 2004; 66:486–91.
  • Okusa MD. The inflammatory cascade in acute ischemic renal failure. Nephron. 2002; 90: 133–8.
  • Sutton TA, Fisher CJ, Molitoris BA. Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int. 2002 ;62: 1539–49.
  • Ikeda M, Prachasilchai W, Burne-Taney MJ, Rabb H, Yokota-Ikeda N. Ischemic acute tubular necrosis models and drug discovery: a focus on cellular inflammation. Drug Discov To-day. 2006; 11: 364–70.
  • Thurman JM. Triggers of inflammation after renal ischemia/ reperfusion. Clin lmmunol. 2007; 123: 7–13.
  • Kelly KJ.Acute renal failure: Much more than a kidney disease. Semin Nephrol. 2006; 26:105–13.
  • Chien C, King LS, Rabb H. Mechanisms underlying combined acute renal failure and acute lung injury in the intensive care unit. Contrib Nephrol. 2004; 144:53–62.
  • Wan L, Bellomo R, Di Giantomasso D, Ronco C. The pathoge-nesis of septic acute renal failure. CurrOpin Crit Care. 2003; 9: 496–502.
  • Kaushal GP, Basnakian AG, Shah SV. Apoptotic pathways in ischemic acute renal failure. Kidney Int. 2004; 66: 500–6.
  • Cantley LG. Adult stem cells in the repair of the injured renal tubule. Nat Clin Pract Nephrol. 2005; 1:22–32.
  • Bates CM, Lin F. Future strategies in the treatment of acute renal failure: growth factors, stem cells, and other novel the-rapies. Curr Opin Pediatr. 2005; 17: 215–20.
  • Sharples EJ, Yaqoob MM. Erythropoietin and acute renal fai-lure. Semin Nephrol. 2006; 26: 325–31.
  • Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA. 1995; 273:117–23.
  • Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med. 2004; 351: 159–69.
  • Brenner M, Schaer GL, Mallory DL, Suffredini AF, Parrillo JE. Detection of renal blood flow abnormalities in septic and cri-tically ill patients using a newly designed indwelling thermo-dilution renal vein catheter. Chest. 1990; 98: 170–9.
  • Langenberg C, Bellomo R, May C, Wan L, Egi M, Morgera S. Renal blood flow in sepsis. Crit Care. 2005; 9: R363–74.
  • Langenberg C, Wan L, Egi M, May CN, Bellomo R. Renal blood flow in experimental septic acute renal failure. Kidney Int. 2006; 69: 1996–2002.
  • Molitoris BA. Renal blood flow in sepsis: a complex issue. Crit Care. 2005; 9: 327–8.
  • El-Achkar TM, Dagher PC. Renal toll-like receptors: recent ad-vances and implications for disease. Nat Clin Pract Nephrol 2006; 2:568–81.
  • Joannidis M. Drug-induced renal failure in the ICU. Int J Artif Org. 2004; 27: 1034–42.
  • Schetz M, Dasta J, Goldstein S, Golper T. Drug-induced acute kidney injury. Curr Opin Crit Care. 2005; 11:555–65.
  • Choudhuryy D, Ahmed Z. Drug-associated renal dysfunction and injury. Nat Clin Pract Nephrol. 2006; 2: 80–91.
  • Fry AC, Farrington K. Management of acute renal failure. Post-grad Med J. 2006; 82: 106–16.
  • Hilton R. Acute renal failure. BMJ. 2006; 333: 786–90.
  • Gottlieb RH, Weinberg EP, Rubens DJ et al. Renal sonography: can it be used more selectively in the setting of an elevated serum creatinine level? Am J Kidney Dis. 1997; 29: 362-7.
  • Keyserling HF, Fielding JR, Mittelstaedt CA. Renal sonography in the intensive care unit: when is it necessary? J Ultrasound Med. 2002; 21:517–20.
  • Carvounis CP, Nisar S, Guro-Razuman S. Significance of the fractional excretion of urea in the differential diagnosis of acute renal failure. Kidney Int. 2002; 62:2223–9.
  • Rivers E, Nguyen B, Havstad S, et al. Early goal-directed the-rapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001; 345: 1368–77.
  • Lin SM, Huang CD, Lin HC, Liu CY, Wang CH, Kuo HP. A modi-fied goal-directed protocol improves clinical outcomes in in-tensive care unit patients with septic shock: a randomized controlled trial. Shock. 2006; 26: 551–7.
  • Shimazu T, Yoshioka T, Nakata Y, et al. Fluid resuscitation and systemic complications in crush syndrome: 14 Hanshin-Awa-ji earthquake patients. J Trauma. 1997; 42:641–6.
  • Gunal Al, Celiker H, Dogukan A, et al. Early and vigorous fluid resuscitation prevents acute renal failure in the crush victims of catastrophic earthquakes. J Am Soc Nephrol. 2004 ; 15: 1862–7.
  • Marathias KP, Vassili M, Robola A, et al. Preoperative intrave-nous hydration confers renoprotection in patients with chro-nic kidney disease undergoing cardiac surgery. Artif Organs. 2006; 30:615–21.
  • Schortgen F, Lacherade JC, Bruneel F, et al. Effects of hydroxy-ethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet. 2001; 357: 911–6.
  • Winkelmayer WC, Glynn R, Levin R, Avorn J. Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgey. Kidney Intern. 2003; 64: 1046–9.
  • Wiesen P, Canivet JL, Ledoux D, Roediger L, Damas P. Effect of hydroxyethylstarch on renal function in cardiac surgery: a large scale retrospective study. Acta Anaesthesiol Belg. 2005; 56: 257–63.
  • Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R; SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004; 350: 2247–56.
  • Trivedi HS, Moore H, Nasr S, et al A randomized prospective trial to assess the role of saline hydration on the development of con-trast nephrotoxicity. Nephron Clin Pract. 2003; 93: C29–34.
  • Mueller C, Buerkle G, Buettner Hi, et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med. 2002; 162: 329–36.
  • Merten GJ, Burgess WP, Gray LV, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled triaLJAMA. 2004; 291: 2328–34.
  • Holmes CL. Vasoactive drugs in the intensive care unit. Curr Opin Crit Care. 2005; 11: 413–7.
  • Bourgoin A, Leone M, Delmas A, Gamier F, Albanese J, Martin C. Increasing mean arterial pressure in patients with septic shock: effects on oxygen variables and renal function. Crit Care Med. 2005; 33: 780–6.
  • Bersten AD, Holt AW. Vasoactive drugs and the importance of renal perfusion pressure. New Horiz. 1995; 3:650–61.
  • Schetz M. Vasopressors and the kidney. Blood Purif. 2002; 20: 243–51.
  • Albanese J, Leone M, Gamier F, Bourgoin A, Antonini F, Martin C. Renal effects of norepinephrine in septic and nonseptic pa-tients. Chest. 2004; 126: 534–9.
  • Malbrain ML, Chiumello D, Pelosi P, et al. Incidence and prog-nosis of intraabdominal hypertension in a mixed population of critically iR patients: a multiple-center epidemiological study. Crit Care Med. 2005; 33:315–22.
  • The Acute Respiratory Distress Network. Ventilation with lo-wer tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syn-drome. N Engl J Med. 2000; 342: 1301–8.
  • Russell JA. Management of sepsis. N Engl J Med. 2006; 355: 1699–713.
  • Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003; 348: 138–50.
  • Dellinger RP, Carlet JM, Masur H et al; Surviving Sepsis Cam-paign Management Guidelines Committee. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004; 32: 858–73.
  • Bernard GR, Vincent JL, Laterre PF, et al; Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety of recombinant human acti-vated protein C for severe sepsis. N Engl J Med. 2001; 344: 699–709.
  • Barclay ML, Kirkpatrick CM, Begg EJ. Once daily aminoglyco-side therapy. Is it less toxic than multiple daily doses and how should it be monitored? Clin Pharmacokinet. 1999; 36:89–98.
  • Johansen HK, Gotzsche PC. Amphotericin B lipid soluble for-mulations vs amphotericin B in cancer patients with neu-tropenia. Cochrane Database Syst Rev 2000; (3): CD000969.
  • Barrett JP, Vardulaki KA, Conlon C, et al; Amphotericin B Syste-matic Review Study Group. A systematic review of the anti-fungal effectiveness and tolerability of amphotericin B for-mulations. Clin Ther. 2003; 25: 1295–1320.
  • Venkataraman R, Kellum JA. Prevention of acute renal failure. Chest. 2007; 131:300–8.
  • Schetz M. Should we use diuretics in acute renal failure? Best Pract Res Clin Anaesthesiol. 2004; 18: 75–89.
  • Ho KM, Sheridan DJ. Meta-analysis of frusemide to prevent or treat acute renal failure. BMJ. 2006 ; 333:420–5.
  • Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of sali-ne, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med. 1994; 331:1416–20.
  • Lassnigg A, Donner E, Grubhofer G, Presterl E, Druml J, Hies-mayr M. Lack of renoprotective effects of dopamine and furo-semide during cardiac surgery. J Am Soc Nephrol. 2000; 11: 97–104.
  • Kellum JA, Decker JM. Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med. 2001; 29: 1526–31.
  • Marik PE. Low-dose dopamine: a systematic review. Intensive Care Med. 2002; 28:877–83.
  • Friedrich JO, Adhikari N, Herridge MS, Beyene J. Meta-analysis: low-dose dopamine increases urine output but does not pre-vent renal dysfunction or death. Ann Intern Med 2005; 142: 310–24.
  • Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Ze-aland Intensive Care Society (ANZICS) Clinical Trials Group. Lancet. 2000; 356: 2139–43.
  • Lauschke A, Teichgraber UK, Frei U, Eckardt KU., Low-dose do-pamine worsens renal perfusion in patients with acute renal failure. Kidney Int. 200; 69: 1669-74.
  • Tumlin JA, Finkel KW, Murray PT, Samuels J, Cotsonis G, Shaw AD. Fenoldopam mesylate in early acute tubular necrosis: a randomized double-blind placebo-controlled clinical trial. Am J Kidney Dis. 2005; 46: 26–34.
  • Morelli A, Ricci Z, Bellomo R, et al. Prophylactic fenoldopam for renal protection in sepsis:A randomized, double-blind, pla-cebo-controlled pilot trial. Crit Care Med. 2005; 33: 2451–6.
  • Landoni G, Biondi-Zoccai GG, Tumlin JA, et al. Beneficial im-pact of fenoldopam in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical tri-als. Am J Kidney Dis. 2007; 49: 56–68.
  • Stone GW, McCullough PA, Tumlin JA, et al; CONTRAST Inves-tigators. Fenoldopam mesylate for the prevention of con-trast-induced nephropathy: a randomized controlled trial. JAMA. 2003; 290:2284–91.
  • Allgren RL, Marbury TC, Rahman SN, et al. Anaritide in acute tubular necrosis.Auriculin Anaritide Acute Renal Failure Study Group. N Engl J Med. 1997; 336:828–34.
  • Lewis J, Salem MM, Chertow GM, et al. Atrial natriuretic factor in oliguric acute renal failure. Anaritide Acute Renal Failure Study Group. Am J Kidney Dis. 2000; 36: 767–74.
  • Sward K, Valsson F, Odencrants P, Samuelsson O, Ricksten SE. Recombinant human atrial natriuretic peptide in ischemic acute renal failure: a randomized placebo-controlled trial. Crit Care Med. 2004; 32: 1310–5.
  • Ku rnik BR, Allgren RL, Genter FC, Solomon RJ, Bates ER, Weis-berg LS. Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. Am J Kidney Dis. 1998; 31:674–80.
  • Bagshaw SM, McAlister FA, Manns BJ, Ghali WA. Acetylcys-teine in the prevention of contrast-induced nephropathy: a case study of the pitfalls in the evolution of evidence. Arch Intern Med. 2006; 166:161–6.
  • Hoffmann U, Fischereder M, Kruger B, Drobni kW, Kramer BK. The value of N-acetylcysteine and contrast-induced nephro-pathy seems questionablejAm Soc Nephrol. 2004; 15: 407–10.
  • Burns KE, Chu MW, Novick RJ, et al. Perioperative N-acetyl-cysteine to prevent renal dysfunction in high-risk patients undergoing cabg surgery: a randomized controlled trial. JAMA. 2005; 294: 342–50.
  • Komisarof JA, Gilkey GM, Peters DM, Koudelka CW, Meyer MM, Smith SM. N-acetylcysteine for patients with prolonged hypotension as prophylaxis for acute renal fa hire (NEPHRON). Crit Care Med. 2007; 35:435–41.
  • Macedo E, Abdulkader R, Castro I, Sobrinho AC, Yu L, Vieira JM Jr. Lack of protection of N-acetylcysteine (NAC) in acute renal failure related to elective aortic aneurysm repair-a ran-domized controlled trial. Nephrol Dial Transplant. 2006; 21:1863–9.
  • Hynninen MS, Niemi TT, Poyhia R, et al. N-acetylcysteine for the prevention of kidney injury in abdominal aortic surgery: a randomized, double-blind, placebo-controlled trial. Anesth Analg. 2006; 102:1638–45.
  • Van den Berghe G, Wouters P, Weekers F, et at. Intensive insu-lin therapy in the critically ill patients. N Engl J Med. 2001; 345:1359–67.
  • Van den Berghe G, Wilmer A, Hermans G, et at. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006; 354:449–61.
  • Gettings LG, Reynolds HN, Scalea T. Outcome in post-trau-matic acute renal failure when continuous renal replacement therapy is applied early vs. late. Intensive Care Med. 1999; 25: 805–13.
  • Demirkilic U, Kuralay E, Yenicesu M, et at. Timing of replace-ment therapy for acute renal failure after cardiac surgery.J Card Surg. 2004; 19: 17–20.
  • Elahi MM, Lim MY, Joseph RN, Dhannapuneni RR, Spyt Ti. Early hemofiltration improves survival in post-cardiotomy patients with acute renal failure. Eur. J Cardiothorac.Surg. 2004; 26: 1027–31.
  • Bouman CS, Oudemans-van Straaten HM, Tijssen JG, Zandstra DF, Kesecioglu J. Effects of early high-volume continuous venove-nous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med. 2002; 30: 2205–11.
  • Ronco C, Bonello M, Bordoni V, et al. Extracorporeal therapies in non-renal disease: treatment of sepsis and the peak con-centration hypothesis. Blood Purif. 2004; 22:164–74.
  • Schetz M. Non-renal indications for continuous renal replace-ment therapy. Kidney Int Suppl. 1999; 72: 588–94.
  • Venkataraman R, Subramanian S, Kellum JA. Clinical review: extracorporeal blood purification in severe sepsis. Crit Care. 2003; 7: 139–45.
  • Tiranathanagul K, Brodie J, Humes HD. Bioartificial kidney in the treatment of acute renal failure associated with sepsis. Nephrology (Carlton). 2006; 11:285–91.
  • Kumar VA, Craig M, Depner TA, Yeun JY. Extended daily dialy-sis:A new approach to renal replacement for acute renal fai-lure in the intensive care unit. Am J Kidney Dis. 2000; 36:294–300.
  • Riser D, Kielstein JT.Technology Insight: treatment of renal failure in the intensive care unit with extended dialysis. Nat Clin Pract Nephrol. 2006; 2: 32–9.
  • Mehta RL, McDonald B, Gabbai FB, et al A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int. 2001; 60: 1154–63.
  • Gasparovic V, Filipovic-Grcic I, Merlder M, Pisl Z. Continuous renal replacement therapy (CRRT) or intermittent hemodia-lysis (IHD)--what is the procedure of choice in critically ill patients? Ren Fail. 2003; 25:855–62.
  • Augustine JJ, Sandy D, Seifert TH, Paganini EP. A randomized controlled trial comparing intermittent with continuous dia-lysis in patients with ARF. Am J Kidney Dis. 2004; 44: 1000–7.
  • Uehlinger DE, Jakob SM, Ferrari P, et al. Comparison of conti-nuous and intermittent renal replacement therapy for acute renal failure. Nephrol Dial Transplant. 2005; 20:1630-7. 150.Vinsonneau C, Camus C, Combes A, et al; Hemodiafe Study Group. Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multi-centre randomised trial. Lancet. 2006; 368: 379–85.
  • Schortgen F. Hypotension during intermittent hemodialysis: new insights into an old problem. Intensive Care Med. 2003; 29: 1645–9.
  • Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous veno-venous haemoffitration on outcomes of acute renal failure: a prospective randomised trial. Lancet. 2000; 356: 26–30.
  • Schiffl H, Lang SM, Fischer R. Daily hemodialysis and the out-come of acute renal failure. N Engl J Med. 2002; 346:305–10.
  • Saudan P, Niederberger M, De Seigneux S, et al. Adding a dia-lysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int. 2006;70: 1312–7.
  • Palevsky PM, O'Connor T, Zhang JH, Star RA, Smith MW. De-sign of the VA/NIH Acute Renal Failure Trial Network (ATN) Study: intensive versus conventional renal support in acute renal failure. Clin Trials. 2005; 2:423–35.
  • Bellomo R. Do we know the optimal dose for renal replace-ment therapy in the intensive care unit? Kidney Int. 2006; 70:1202–4.
  • Kindgen-Milles D, Journois D, Fumagalli R, et al. Study proto-col:The DOse REsponse Multicentre International collabora-tive initiative (DO-RE-MI). Crit Care. 2005; 9: R396–406.
  • Chertow GM, Christiansen CL, Cleary PD, Munro C, Lazarus J M. Prognostic stratification in critically ill patients with acute renal failure requiring dialysis. Arch Intern Med. 1995; 155: 1505–11.
  • Neveu H, Kleinknecht D, Brivet F, Loirat P, Landais P. Prognos-tic factors in acute renal failure due to sepsis. Results of a prospective multicentre study. The French Study Group on Acute Renal Failure. Nephrol Dial Transplant 1996; 11: 293–9.
  • Chertow GM, Soroko SH, Paganini Ep et al. Mortality after acute renal failure: models for prognostic stratification and risk adjustment. Kidney Int. 2006; 70: 1120–6.
  • Ahlstrom A, Tallgren M, Peltonen S, Rasanen P, Pettila V. Survi-val and quality of life of patients requiring acute renal re-placement therapy. Intensive Care Med. 2005; 31: 1222–8
  • Gopal I, Bhonagiri S, Ronco C, Bellomo R. Out of hospital out-come and quality of life in survivors of combined acute mul-tiple organ and renal failure treated with continuous venove-nous hemofiltration/hemodiafiltration. Intensive Care Med. 1997; 23: 766–72.
  • Bhandari S, Turney JH. Survivors of acute renal failure who do not recover renal function. QJM. 1996; 89:415–21.
  • McCarthy JT. Prognosis of patients with acute renal failure in the intensive-care unit: a tale of two eras. Mayo Clin Proc. 1996; 71:117–26.
  • Bagshaw SM, Mortis G, Godinez-Luna T, Doig CJ, Lau pland KB. Renal recovery after severe acute renal failure. Int J Artif Or-gans. 2006; 29: 1023–30.
  • Schiffl H. Renal recovery from acute tubular necrosis requi-ring renal replacement treatment: a prospective study in cri-tically ill patients. Nephrol Dial Transplant. 2006; 21: 533–40.
  • Spurney RF, Fulkerson WJ, Schwab Si Acute renal failure in cri-tically ill patients: prognosis for recovery of kidney function after prolonged dialysis support. Crit Care Med. 1991; 19:8–11.
  • Basile DP. Novel approaches in the investigation of acute kid-ney injury. J Am Soc Nephrol 2007; 18: 7–9.
  • Block CA, Schoolwerth AC.The epidemiology and outcome of acute renal failure and the impact on chronic kidney disease. Semin Dial. 2006; 19: 450–4

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.